Insmed Inc (INSM)
72.28
+0.88
(+1.23%)
USD |
NASDAQ |
Oct 04, 16:00
72.22
-0.06
(-0.08%)
After-Hours: 20:00
Insmed Shareholders Equity (Annual): -331.92M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -331.92M |
| December 31, 2022 | 87.95M |
| December 31, 2021 | 410.47M |
| December 31, 2020 | 275.88M |
| December 31, 2019 | 261.67M |
| December 31, 2018 | 208.27M |
| December 31, 2017 | 361.06M |
| December 31, 2016 | 154.48M |
| December 31, 2015 | 311.70M |
| December 31, 2014 | 186.24M |
| December 31, 2013 | 143.32M |
| December 31, 2012 | 120.88M |
| December 31, 2011 | 134.27M |
| Date | Value |
|---|---|
| December 31, 2010 | 192.84M |
| December 31, 2009 | 123.91M |
| December 31, 2008 | -2.823M |
| December 31, 2007 | 11.49M |
| December 31, 2006 | 13.88M |
| December 31, 2005 | 10.53M |
| December 31, 2004 | 7.235M |
| December 31, 2003 | 26.22M |
| December 31, 2002 | 23.45M |
| December 31, 2001 | 59.70M |
| December 31, 2000 | 96.78M |
| December 31, 1999 | 4.461M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-331.92M
Minimum
2023
410.47M
Maximum
2021
140.81M
Average
261.67M
Median
2019
Shareholders Equity (Annual) Benchmarks
| Fulcrum Therapeutics Inc | 235.19M |
| Eli Lilly and Co | 10.77B |
| Bioventus Inc | 173.59M |
| Entrada Therapeutics Inc | 242.36M |
| NovaBay Pharmaceuticals Inc | 3.314M |